C07D 211/60
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D211/60 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 1,855 US grants and 1,720 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,855
- Published applications
- 1,720
- Assignees
- 795
- Inventors
- 5,339
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 25 | 0 |
| 1978 | 51 | 0 |
| 1979 | 31 | 0 |
| 1980 | 28 | 0 |
| 1981 | 23 | 0 |
| 1982 | 14 | 0 |
| 1983 | 13 | 0 |
| 1984 | 13 | 0 |
| 1985 | 11 | 0 |
| 1986 | 10 | 0 |
| 1987 | 9 | 0 |
| 1988 | 15 | 0 |
| 1989 | 13 | 0 |
| 1990 | 6 | 0 |
| 1991 | 19 | 0 |
| 1992 | 22 | 0 |
| 1993 | 21 | 0 |
| 1994 | 20 | 0 |
| 1995 | 10 | 0 |
| 1996 | 33 | 0 |
| 1997 | 63 | 0 |
| 1998 | 63 | 0 |
| 1999 | 49 | 0 |
| 2000 | 47 | 0 |
| 2001 | 48 | 15 |
| 2002 | 67 | 64 |
| 2003 | 42 | 84 |
| 2004 | 49 | 110 |
| 2005 | 40 | 87 |
| 2006 | 50 | 104 |
| 2007 | 46 | 80 |
| 2008 | 39 | 57 |
| 2009 | 69 | 67 |
| 2010 | 56 | 67 |
| 2011 | 46 | 68 |
| 2012 | 50 | 53 |
| 2013 | 44 | 47 |
| 2014 | 57 | 78 |
| 2015 | 47 | 90 |
| 2016 | 56 | 77 |
| 2017 | 78 | 68 |
| 2018 | 57 | 67 |
| 2019 | 65 | 70 |
| 2020 | 46 | 62 |
| 2021 | 44 | 53 |
| 2022 | 32 | 46 |
| 2023 | 37 | 65 |
| 2024 | 24 | 50 |
| 2025 | 37 | 53 |
| 2026 | 12 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors28 Jul 2026US 12,692,239 B2Nanjing Immunophage Biomedical Co., Ltd.
- Amino lipid and preparation method and application thereof14 Jul 2026US 12,679,801 B2Shenzhen MagicRNA Biotechnology Co., Ltd.
- Luminally-acting N-(piperidin-4-yl)benzamide derivatives16 Jun 2026US 12,653,815 B2Takeda Pharmaceutical Company Limited
- Crystal form of muscarine antagonist, method for preparing same, and use thereof24 Sep 2026US 2026/0285810 A1Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
- Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia17 Sep 2026US 2026/0274785 A1Atrogi AB
- Long-chain alkenyloxy-substituted benzoyl derivative and oligonucleotide synthesis method using same17 Sep 2026US 2026/0274885 A1SPERA PHARMA, Inc.
- Local anesthetics with selective-sensory nerve blockade27 Aug 2026US 2026/0250249 A1Children's Medical Center Corporation
- Lipid compounds, compositions, and uses thereof20 Aug 2026US 2026/0242346 A1Liberate Bio, Inc.
Most cited
By later US patents
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Proline derivatives and related compounds230US 4,105,776 AE. R. Squibb & Sons, Inc. · 1978
- Azetidine-2-carboxylic acid derivatives180US 4,046,889 AE. R. Squibb & Sons, Inc. · 1977
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Inhibitors of microsomal triglyceride transfer protein and method137US 5,712,279 ABristol-Myers Squibb Company · 1998